share_log

Aditxt | PRER14A: Preliminary revised proxy soliciting materials

Aditxt | PRER14A: Preliminary revised proxy soliciting materials

Aditxt | PRER14A：初步修订代理权征集材料
美股SEC公告 ·  2024/07/02 00:42

Moomoo AI 已提取核心信息

Aditxt, Inc. has announced its upcoming annual meeting of stockholders to be held virtually in July 2024. During the meeting, stockholders will vote on critical proposals, including the election of board members, ratification of the independent accounting firm dbbmckennon for the fiscal year ending December 31, 2024, and approval of various corporate actions. These actions encompass the issuance of common stock underlying Series B-1 and B-2 Convertible Preferred Stock, common stock issuance under a $150 million equity line of credit, and an increase in authorized shares of common stock from 100 million to 1 billion. Additionally, the board seeks approval for a potential reverse stock split and an amendment to increase the number of shares issuable under the 2021 Omnibus Equity Incentive Plan. The board has set June 4, 2024, as the record date for stockholders' eligibility to vote, and electronic voting will be available during the meeting. The proxy statement is accessible at www.proxyvote.com, and stockholders are encouraged to vote via proxy promptly.
Aditxt, Inc. has announced its upcoming annual meeting of stockholders to be held virtually in July 2024. During the meeting, stockholders will vote on critical proposals, including the election of board members, ratification of the independent accounting firm dbbmckennon for the fiscal year ending December 31, 2024, and approval of various corporate actions. These actions encompass the issuance of common stock underlying Series B-1 and B-2 Convertible Preferred Stock, common stock issuance under a $150 million equity line of credit, and an increase in authorized shares of common stock from 100 million to 1 billion. Additionally, the board seeks approval for a potential reverse stock split and an amendment to increase the number of shares issuable under the 2021 Omnibus Equity Incentive Plan. The board has set June 4, 2024, as the record date for stockholders' eligibility to vote, and electronic voting will be available during the meeting. The proxy statement is accessible at www.proxyvote.com, and stockholders are encouraged to vote via proxy promptly.
Aditxt公司已宣布将于2024年7月以虚拟方式举行股东年会。在会议期间，股东将就关键提案进行投票，包括选举董事会成员，批准独立会计事务所dbbmckennon审核截至2024年12月31日的财年，并批准各种公司行动。这些行动包括发行B-1和B-2可转换优先股的普通股，根据1.5亿美元的股本信贷额度发行普通股，将普通股的授权股份从1亿股提高到10亿股。此外，董事会正在寻求批准潜在的股票拆分和修改以增加2021年全面股权激励计划可发行股份的数量。董事会已将2024年6月4日设为股东资格登记日，并将在会议期间提供电子投票。代理声明可在www.proxyvote.com获取，建议股东尽快通过代理投票。
Aditxt公司已宣布将于2024年7月以虚拟方式举行股东年会。在会议期间，股东将就关键提案进行投票，包括选举董事会成员，批准独立会计事务所dbbmckennon审核截至2024年12月31日的财年，并批准各种公司行动。这些行动包括发行B-1和B-2可转换优先股的普通股，根据1.5亿美元的股本信贷额度发行普通股，将普通股的授权股份从1亿股提高到10亿股。此外，董事会正在寻求批准潜在的股票拆分和修改以增加2021年全面股权激励计划可发行股份的数量。董事会已将2024年6月4日设为股东资格登记日，并将在会议期间提供电子投票。代理声明可在www.proxyvote.com获取，建议股东尽快通过代理投票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Dogwood Therapeutics
    DWTX
    -- 13.350
    Transcode Therapeutics
    RNAZ
    -- 5.500
    Evaxion Biotech
    EVAX
    -- 3.640
    Hepion Pharmaceuticals
    HEPA
    -- 0.2000
    Nutriband
    NTRB
    -- 9.900
    解锁完整榜单
    热门中概股
    追踪最热门的中概股实时资讯。
    热门讨论
    1月议息会议来袭！美联储暂停降息已成定局？
    🎙️讨论 1. 美联储是否如期按下降息“暂停键”？ 2. 你觉得特朗普总统的政治举措会改变美联储的立场吗？ 3. 你会如何调整你的持仓配置？ 展开
    这是十二月消费指数的详细情况，一览无余